Azmil H. Abdul‐Rahim

Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

Sonia S. Anand, Jackie Bosch, John W. Eikelboom et al. · The Lancet · 2017 · 855 citations · Full text

Thrombosis, Cardiovascular Disease, Stroke +13

Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial

Daniel F. Hanley, Richard E. Thompson, Michael Rosenblum et al. · The Lancet · 2019 · 850 citations · Full text

Thrombosis, Endpoint Phase 3, Interventional Neuroradiology +12

Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

Stuart J. Connolly, John W. Eikelboom, Jackie Bosch et al. · The Lancet · 2017 · 749 citations · Full text

Thrombosis, Cardiovascular Disease, Atherosclerosis +12

Early Recurrence and Cerebral Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation

Maurizio Paciaroni, Giancarlo Agnelli, Nicola Falocci et al. · Stroke · 2015 · 271 citations · Full text

Depression and anxiety symptoms post-stroke/TIA: prevalence and associations in cross-sectional data from a regional stroke registry

Niall M. Broomfield, Terence J. Quinn, Azmil H. Abdul‐Rahim et al. · BMC Neurology · 2014 · 139 citations · Full text